How to better systematize the diagnosis of neuropathy?

Diabetes and Metabolism

Volumn 32, Issue 4, 2006, Pages 367-372

  Gin, H ^a   Perlemoine, C ^a   Rigalleau, V ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Diabetic neuropathy

Indexed keywords

ACHILLES REFLEX; ATAXIA; CLINICAL EXAMINATION; CLINICAL PRACTICE; CORRELATION COEFFICIENT; DIABETIC NEUROPATHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; ELECTROMYOGRAPHY; EQUIPMENT; FUNCTIONAL ASSESSMENT; HUMAN; MEDICAL PRACTICE; MUSCLE WEAKNESS; NEUROLOGIC EXAMINATION; OBSERVER VARIATION; PHYSICAL EXAMINATION; PROGNOSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SENSATION; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SENSORY ANALYSIS; SYMPTOMATOLOGY;

EID: 33748790690     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70293-8     Document Type: Article

References (27)

1. Vinik AI, Park TS, Stansberry KB, et al. Diabetic neuropathies. Diabetologia 2000;43:957-73.
2. Cabezas-Cerrato J for the Neuropathy Spanish Study Group of the Spanish Diabetes Society (SDS). The prevalence of clinical diabetic polyneuropathy in Spain: a study in promary care and hospital clinic groups. Diabetologia 1998;41:1263-9.
3. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
4. Vinik A. Diabetic neuropathy: pathogenesis and therapy. Am J Med 1999;107:175-265.
5. Perkins BA, Bril V. Diabetic neuropathy: a review emphasizing diagnostic methods. Clin Neurophysiol 2003;114:1167-75.
6. Boulton JM, Malik RA, Arezzo JC, et al. Diabetic somatic neuropathies. Diabetes Care 2004;27:1458-86.
7. Boulton JM, Vinik I, Arezzo C, et al. Diabetic neuropathies. A statement by the American Diabetes Association. Diabetes Care 2005;28:956-62.
8. HAS. Prise en charge diagnostique des polyneuropathies. Recommandations 2006 (sous presse).
9. Andersen H, Gjerst MD, Jakobsen J. Atrophy of foot muscles. A measure of diabetic neuropathy. Diabetes Care 2004;27:2382-5.
10. Booth J, Young MJ. Differences in the performance of commercially available 10-g monofilaments. Diabetes Care 2000;23:984-8.
11. Valk GD, De Sonnaville JJ, Van Houtum WH, et al. The assessment of diabetic polyneuropathy in daily clinical practice; reproductibility and variability of Semmes-Weinstein monofilament examination and clinical neurological examination. Muscle Nerve 1997;20:116-8.
12. Kamei N, Yamane K, Nakanishi S, et al. Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening. J Diabetes Complications 2005;19:47-53.
13. Nagai V, Sugiyama Y, ABE T, Vomura G. 4-g monofilament is clinically useful for detecting diabetic peripheral neuropathy. Diabetes Care 2001;24:183-4.
14. Miranda-Palma B, Sosenko JM, Bowker JH, et al. A comparison of the monofilament with other testing modalities for foot ulcer susceptibility. Diabetes Res Clin Pract 2005;70:8-12.
15. Mcgill M, Molyneaux L, Spencer R, et al. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Diabetes Care 1999;22:598-02.
16. Meijer JVG, Smit AJ, Lefrandt D, et al. Lack to basics in diagnosing diabetic poly-neuropathy with the tuning fork Diabetes Care 2005;28:2201-05.
17. Gin H, Rigalleau V, Baillet L, et al. Comparison between monofilament, tuning fork and vibration perception tests for screening patients at risk of foot complication. Diabetes Metab 2002;28:457-61.
18. Young MJ, Veves A, Boulton AJM. The prediction of diabetic neuropathic foot ulceration using V.P.T. Diabetes Care 1999;17:557-61.
19. Kramer HH, Rolke R, Bickel A, et al. Thermal thresholds predict painfulness of diabetic neuropathies. Diabetes Care 2004;27:2386-91.
20. Ziegler D, Siekierka-Kleiser E, Meyer B, et al. Validation of a novel screening device (Neuro Quick) for quantitative assessment of small nerve fiber dysfunction as an early feature of diabetic polyneuropathy. Diabetes Care 2005;28:1169-74.
21. Young MJ, Boulton AJM, Macleod AF, et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993;36:150-4.
22. Meijer JWG, Smit AJ, Sonderen EV, et al. Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the diabetic neuropathy symptom score. Diabet Med 2002;19:962-5.
23. Abbott CA, Carrington AL, Ashe H, et al. The North-West diabetes foot care study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med 2002;19:377-84.
24. Feldman EE, Stevens MJ, Thomas PK, et al. A practical two-step quantitative clinical and electrophysiological assessment fot the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-9.
25. Lunetta M, Le Moli R, Grasso G, et al. A simplified diagnostic test for ambulatory screening of peripheral diabetic neuropathy. Diabetes Res Clin Pract 1998;39:165-72.
26. Coppini DV, Wellmer A, Weng C, et al. The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds. J Clin Neurosci 2001;8:520-4.
27. Liniger C, Albeanu A, Moody JF, et al. The thermocross: a simple tool for rapid assessment of thermal sensation thresholds. Diabetes Res Clin Pract 1991;12:25-33.